Ozempic’s most common side effects are gastrointestinal: nausea, diarrhea, vomiting, and constipation. These affect roughly 1 in 5 users and are most intense during the first four weeks of treatment or after a dose increase. Most people find they fade as the body adjusts, but a smaller number experience more serious complications that are worth understanding before you start.
Why Ozempic Causes Stomach Problems
Ozempic (semaglutide) mimics a gut hormone called GLP-1. When you eat, your body naturally releases GLP-1 to signal your pancreas to produce insulin, tell your brain you’re full, and slow the rate food leaves your stomach. Ozempic amplifies all three of those signals. The slowed stomach emptying is what makes you feel satisfied on less food, but it’s also what triggers nausea, bloating, and vomiting. Your stomach is simply holding onto food longer than it used to.
Common Side Effects by Dose
Side effect rates climb with the dose. In clinical trials, nausea occurred in 17% of people on the 0.5 mg dose and about 20% on the 1 mg dose. Diarrhea affected 12% and 13%, respectively, while vomiting hit 6.4% and 8.4%. That’s why Ozempic uses a slow titration schedule: you start at a low dose and increase gradually over weeks, giving your body time to adapt.
Most of these symptoms are mild to moderate and resolve after the dose escalation phase. In trials, about 6% of people on 0.5 mg and nearly 9% on 1 mg discontinued treatment because of side effects, compared to just 1.5% on placebo. So while the majority push through, a meaningful number find the GI effects intolerable.
Reducing Nausea and GI Distress
What you eat matters more on Ozempic than it did before. Greasy, fried, and heavily processed foods tend to make nausea worse because your stomach is already working slowly. Spicy food can aggravate symptoms too. When nausea hits, bland options like crackers, toast, rice, and broth-based soup are your safest bet.
Eating smaller meals every three hours or so, rather than two or three large ones, helps keep your slowed digestive system from getting overwhelmed. Each meal or snack should include some protein, a carbohydrate, and a healthy fat to stay balanced. Alcohol can worsen nausea and vomiting for some people, so it’s worth cutting back, at least early on. A short walk after eating also helps move food through your system.
Muscle Loss During Weight Loss
This side effect doesn’t show up on a symptom checklist, but it’s significant. When you lose weight on Ozempic, not all of it is fat. Studies published in The Lancet Diabetes & Endocrinology show that 25% to 39% of total weight lost on GLP-1 medications is lean mass, which includes muscle. That’s notably higher than the 10% to 30% lean mass loss seen with standard calorie-cutting diets.
To put that in perspective, the annual rate of muscle loss on these medications is several times greater than what you’d expect from normal aging, which averages about 0.8% per year between ages 40 and 70. This matters because muscle supports your metabolism, protects your joints, and helps maintain mobility as you age. Resistance training and adequate protein intake become especially important if you’re on Ozempic long-term.
Gallbladder Problems
About 1 in 100 people on Ozempic develop gallstones, and roughly 1 in 1,000 develop a gallbladder infection. Overall, fewer than 2% of users experienced any gallbladder problem in clinical trials. Interestingly, the rate of gallstones was actually higher at the lower 0.5 mg dose (1.5%) than at 1 mg (0.4%) in placebo-controlled trials, which may reflect differences in study populations rather than a true dose relationship.
Symptoms of gallbladder trouble include sudden, intense pain in your upper right abdomen, nausea that feels different from the usual Ozempic-related queasiness, and sometimes fever. Rapid weight loss from any cause raises gallstone risk, so this isn’t unique to Ozempic, but it’s worth being aware of.
Gastroparesis and Bowel Obstruction
The slowed stomach emptying that causes mild nausea in most people can, in rare cases, become severe enough to qualify as gastroparesis, sometimes called stomach paralysis. A large study from the University of British Columbia examined insurance records for about 16 million U.S. patients and found that GLP-1 medications were associated with a 3.67 times higher risk of gastroparesis and a 4.22 times higher risk of bowel obstruction compared to another weight loss drug.
Gastroparesis symptoms include persistent vomiting, severe nausea, and abdominal pain that doesn’t improve with the usual dietary adjustments. Bowel obstruction causes intense cramping, bloating, and vomiting, and can sometimes require surgery. These are uncommon outcomes, but the warning labels for Ozempic don’t currently include gastroparesis as a listed risk, something researchers have urged regulators to address.
Vision Changes in People With Diabetes
If you have type 2 diabetes with existing eye damage, Ozempic carries a specific risk. In the SUSTAIN-6 trial, semaglutide was linked to a 76% higher rate of retinopathy complications, including bleeding in the eye and decreased vision in some patients. This led the FDA to add warnings about vision changes to the Ozempic label.
The risk appears tied to how quickly blood sugar drops rather than the medication itself. When blood sugar levels fall rapidly, damaged blood vessels in the retina can worsen before they improve. If you have diabetic eye disease, close monitoring from an eye specialist during the first months of treatment is important.
The Thyroid Warning
Ozempic carries the FDA’s most serious label, a boxed warning, for thyroid tumor risk. In animal studies, semaglutide caused thyroid C-cell tumors at doses comparable to what humans take, and the risk increased with both dose and duration. Whether this translates to humans remains unknown.
Because of this uncertainty, Ozempic is not prescribed to anyone with a personal or family history of medullary thyroid carcinoma or a condition called Multiple Endocrine Neoplasia syndrome type 2. Signs of thyroid tumors include a lump or swelling in the neck, difficulty swallowing, hoarseness, and shortness of breath.
Injection Site Reactions
Since Ozempic is a weekly injection, some people develop redness, rash, or irritation at the injection site. This is uncommon, affecting about 0.5% to 0.6% of users in trials regardless of dose. Rotating your injection location between your abdomen, thigh, and upper arm can help minimize it.